These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
132 related items for PubMed ID: 38235642
21. Predictors of anti-VEGF efficacy in chronic central serous chorioretinopathy based on intraocular cytokine levels and pigment epithelium detachment subtypes. Mao J, Zhang C, Zhang S, Liu C, Chen N, Tao J, She X, Zheng Z, Lv Z, Shen L. Acta Ophthalmol; 2022 Nov; 100(7):e1385-e1394. PubMed ID: 35122421 [Abstract] [Full Text] [Related]
26. Pachychoroid Spectrum Disease: Comparison of Patients with Central Serous Chorioretinopathy Complicated with Pachychoroid Neovasculopathy. Jung H, Suh Y, Lee J, Lee CS, Kim M, Byeon SH, Kim SS, Kang HG. Korean J Ophthalmol; 2024 Aug; 38(4):304-315. PubMed ID: 39013560 [Abstract] [Full Text] [Related]
27. Optical coherence tomography angiography of flat irregular pigment epithelial detachments in central serous chorioretinopathy. Liu T, Lin W, Zhou S, Meng X. Br J Ophthalmol; 2021 Feb; 105(2):233-238. PubMed ID: 32265200 [Abstract] [Full Text] [Related]
31. Association of Upregulated Angiogenic Cytokines With Choroidal Abnormalities in Chronic Central Serous Chorioretinopathy. Terao N, Koizumi H, Kojima K, Yamagishi T, Nagata K, Kitazawa K, Yamamoto Y, Yoshii K, Hiraga A, Toda M, Kinoshita S, Sotozono C, Hamuro J. Invest Ophthalmol Vis Sci; 2018 Dec 03; 59(15):5924-5931. PubMed ID: 30551200 [Abstract] [Full Text] [Related]
38. Clinical Features of Central Serous Chorioretinopathy With Type 1 Choroidal Neovascularization. Shiragami C, Takasago Y, Osaka R, Kobayashi M, Ono A, Yamashita A, Hirooka K. Am J Ophthalmol; 2018 Sep 03; 193():80-86. PubMed ID: 29940168 [Abstract] [Full Text] [Related]